Skip To Main Content
Torben Barington on Muck Rack

Torben Barington

As seen in: Patient Education and Counseling, OncoDaily
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Torben

Contact Torben, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Yan Leyfman: CAR NK Cells - The Future of Cancer and Autoimmune Therapy?  - OncoDaily

|
By Emil Christensen, Mike Bogetofte Barnkob, Torben Barington
| OncoDaily
Yan Leyfman, Co-founder and Executive Director of MedNews Week, shared a post on LinkedIn: “CAR NK Cells: The Future of Cancer and Autoimmune Therapy? Chimeric antigen receptor (CAR) NK cell therapy is emerging as a safer, more versatile alternative to CAR T cell therapy, showing promising efficacy in hematologic cancers while reducing severe side effects like CRS, ICANS, and GvHD.
Open in Who Shared Issue with article?

Effect of family nursing therapeutic conversations on health-related quality of life, self-care and depression among outpatients with heart failure: A randomized multi-centre trial

|
By Birte Østergaard, Romy Mahrer-Imhof, Lis Wagner, Torben Barington
| Patient Education and Counseling Verified
Publication HistoryPublished online: March 07, 2018Accepted: March 4, 2018; Received in revised form: February 23, 2018; Received: August 17, 2017;
Open in Who Shared Issue with article?
|
By Anja Mose, Charlotte G Mortz, Esben Eller, Torben Barington, Carsten Bindslev-Jensen, Ulrik Sprogøe
| secure.jbs.elsevierhealth.com
Open in Who Shared Issue with article?
See all 4 articles